F-star Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
F-star Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2022.
  • F-star Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $2.5M, a 28.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $2.5M -$1M -28.6% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.76M -$998K -26.6% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $3.03M -$944K -23.7% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $3.28M +$499K +17.9% Dec 31, 2021 10-Q 2022-11-10
Q3 2021 $3.5M +$997K +39.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.76M +$1.18M +45.9% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $3.98M +$1.33M +50.2% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $2.78M +$2.18M +358% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $2.5M -$280K -10.1% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $2.58M -$274K -9.61% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $2.65M -$267K -9.16% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $607K Dec 31, 2019 10-K 2021-03-30
Q3 2019 $2.78M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $2.85M Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $2.92M Mar 31, 2019 10-Q 2019-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.